Taylor Dillard
Frisco, TXNPI 1205636461
Payments from drug & device makers
Across 79 payments — averaging $23.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$493
- SK Life Science, Inc.$192
- Argenx US, Inc.$180
- UCB, Inc.$139
- Eisai Inc.$113
- Amneal Pharmaceuticals LLC$82
- plus $619 from 14 others
What the payments were for
- Food & beverage$1,817100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $493 |
| SK Life Science, Inc. | 6 | $192 |
| Argenx US, Inc. | 6 | $180 |
| UCB, Inc. | 9 | $139 |
| Eisai Inc. | 5 | $113 |
| Amneal Pharmaceuticals LLC | 5 | $82 |
| Johnson & Johnson | 4 | $82 |
| Jazz Pharmaceuticals Inc. | 3 | $82 |
| Biogen | 3 | $74 |
| AstraZeneca | 3 | $72 |
| TG Therapeutics, Inc. | 3 | $72 |
| Tanabe Pharma America, Inc. | 2 | $52 |
| Amgen | 2 | $32 |
| Lundbeck LLC | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $23 |
| Pfizer | 1 | $21 |
| CSL Behring | 1 | $17 |
| Neurelis, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.